Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience

KILIÇ, LEVENT; KARADAĞ, ÖMER; Erden, Abdumlsaet; SARI, ALPER; ARMAĞAN, BERKAN; YARDIMCI, GÖZDE; FIRAT, ESRA; KALYONCU, UMUT; Apras Bilgen, Sule; KİRAZ, SEDAT; Ertenli, Ihsan; AKDOĞAN, ALİ

doi:10.3906/sag-1906-39

Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience

Copy For Citation

KILIÇ L. , KARADAĞ Ö. , Erden A., SARI A. , ARMAĞAN B. , YARDIMCI G. K. , ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.1, pp.31-36, 2020 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 50 Issue: 1
Publication Date: 2020
Doi Number: 10.3906/sag-1906-39
Title of Journal : TURKISH JOURNAL OF MEDICAL SCIENCES
Page Numbers: pp.31-36

Abstract

Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu's arteritis (TA) patients who are unresponsive to corticosteroids +/- conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety of anti-IL-6 (tocilizumab) therapy in refractory TA patients in real life.